Kevin Grove

Novo Nordisk
Scientific VP of Global Obesity and Liver Disease Research

Kevin Grove, PhD currently serves as the Scientific Vice President, Global Obesity and Liver Disease Research of Novo Nordisk.

Dr. Grove is a renowned academic and industry scientist with an unrelentless drive to understand the biology of obesity, and associated metabolic complications, to find new treatment for patients living with this complex disease. Dr. Grove is currently the Scientific Vice President within the Global Obesity and Liver Disease area and responsible for the early discovery programs at Novo Nordisk’s research center in Seattle, Washington, USA. Since joining Novo Nordisk in September 2014, Dr.Grove has built an exceptional team of scientists from around the world, with biological expertise in brain, muscle, liver and adipose tissues. This highly talented team researches the biologic underpinnings of obesity and liver disease, to discovernew biological entities and mechanisms to control appetite and increase metabolism.

The Seattle obesity team partners with other global Novo Nordisk research sites, and with academic and biotech organizations via formal research collaborations. to advance understanding of the disease. In2017, Dr. Grove was made the Scientific VP for the Obesity Therapy Area and in 2021 this was expanded to include liver disease.

Kevin Grove spent 20 plus years as an academic scientist at Oregon Health Sciences University focusing on pregnancy health and nutrition and the impacts on fetal growth and development. Dr. Grove also led a program focused on progressive pathogenesis of adult onset obesity, with a special focus on developing treatments and interventions for this chronic disease. Prior to that, Dr. Grove received his Ph.D. in Neuroscience and Pharmacology at Washington State University, and completed a postdoctoral fellowship in the Clinical Research Institute of Montreal.  He went to Oregon Health & Science University and the Oregon National Primate Research Center in 1996 as a Staff Scientist and moved up the ranks to finally become a Division Chief of the Division of Diabetes, Obesity, & Metabolism at ONPRC.